Literature DB >> 9636872

Clinical significance and outcome of anaerobic bacteremia.

J H Salonen1, E Eerola, O Meurman.   

Abstract

We retrospectively studied the incidence of anaerobic bacteremia during 6 years (1991-1996) at Turku University Central Hospital (Turku, Finland). The clinical significance of a positive anaerobic blood culture, the effect of a positive culture on the choice of antimicrobial therapy, and the outcome for patients were evaluated. Cultures of blood from 81 patients yielded anaerobic bacteria (4% of all bacteremias). Anaerobic bacteremia was clinically significant in 57 patients (0.18 cases per 1,000 admissions). Only half (28) of these patients received appropriate and effective antimicrobial treatment before the results of blood cultures were reported; for 18 patients (32%), initially ineffective treatment was changed on the basis of the bacteriologic results, and for 11 patients (19%), the treatment was not changed. The mortality in these patient groups was 18%, 17%, and 55%, respectively. Empirical therapy may provide coverage for anaerobes in only half of the patients with anaerobic bacteremia, and failure to pay attention to the results of anaerobic blood cultures may have serious consequences for patients.

Entities:  

Mesh:

Year:  1998        PMID: 9636872     DOI: 10.1086/516355

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  30 in total

1.  Controlled clinical comparison of BACTEC plus anaerobic/F to standard anaerobic/F as the anaerobic companion bottle to plus aerobic/F medium for culturing blood from adults.

Authors:  M L Wilson; S Mirrett; F T Meredith; M P Weinstein; V Scotto; L B Reller
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

3.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

Review 4.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Authors:  Carmen Betriu; Esther Culebras; María Gómez; Fátima López; Iciar Rodríguez-Avial; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

6.  Are incidence and epidemiology of anaerobic bacteremia really changing?

Authors:  A Vena; P Muñoz; L Alcalá; A Fernandez-Cruz; C Sanchez; M Valerio; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-28       Impact factor: 3.267

7.  A comparison of Sensititre™ Anaerobe MIC plate with ATB ANA® test for the routine susceptibility testing of common anaerobe pathogens.

Authors:  Abdessalam Cherkaoui; Adrien Fischer; Nouria Azam; Arnaud Riat; Jacques Schrenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-06       Impact factor: 3.267

8.  Risk Factors for Resistance to β-Lactam/β-Lactamase Inhibitors and Ertapenem in Bacteroides Bacteremia.

Authors:  Janessa M Smith; Edina Avdic; Pranita D Tamma; Long Zhang; Karen C Carroll; Sara E Cosgrove
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

9.  Bacteriology of peritonsillar abscess in patients over 40 years--a neglected age group.

Authors:  Haim Gavriel; Yitzhak Golan; Tsilia Lazarovitch; Ephraim Eviatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-08       Impact factor: 2.503

10.  The Addition of Anaerobic Blood Cultures for Pediatric Patients with Concerns for Bloodstream Infections: Prevalence and Time to Positive Cultures.

Authors:  Jennifer Dien Bard; Todd P Chang; Rebecca Yee; Keya Manshadi; Nhan Lichtenfeld; Hee Jae Choi; Ara Festekjian
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.